25 The scientific literature is vast, growing, and increasingly specialized, making it difficult to 26 connect disparate observations across subfields. To address this problem, we sought to develop 27 automated hypothesis generation by networking at scale the MeSH terms curated by the National 28 Library of Medicine. The result is a Mesh Term Objective Reasoning (MeTeOR) approach that 29 tallies associations among genes, drugs and diseases from PubMed and predicts new ones.
, and we hypothesized that MeTeOR would be able to extract known and 247 novel associations from the wealth of extant literature.
248
We first needed to understand EGFR's known and verifiable associations. MeTeOR 249 found 1064 genes connected to EGFR via MeSH terms in at least one article, 467 genes in at 250 least two articles, and 97 genes in at least ten articles. Assuming that associations made by more 251 articles would be more robust, we compared the MeTeOR-ranked list of 1064 gene-EGFR 252 associations against the MSIGDB pathway standard used in Figure 2 .
253 MeTeOR recovered pathway information better than the text-mining algorithm EVEX 254 (overall AUC MeTeOR of 0.88 vs AUC EVEX of 0.69; Figure 3A ). MeTeOR's initial recall was also 255 superior, as indicated by the Precision-Recall curve (Figure 3B ). Finally, MeTeOR was overall 256 more accurate than STRING Literature (AUC STRING of 0.75), although in the initial recall, 257 STRING did better, likely because it weighs confidence based on KEGG pathway information 258 [49] ( Figure 3B ).
259
We then sought to evaluate MeTeOR's likelihood of generating false positives. Reliance 260 on MeSH terms could, for example, create a spurious link between EGFR and another gene if the 261 publication is a review article that mentions another gene without actually proposing a 262 relationship with EGFR. We noticed that 12 of the top 20 genes MeTeOR associated with EGFR 263 did not appear in MSIGDB pathway standard (Figure 3C, Supplemental Fig. 5 ). We therefore 264 compared these top 20 genes against experimental associations derived from public sources 265 (aggregated in STRING-Experimental). The STRING-Experimental dataset (STRING-EXP), 266 which showed that 13 out of the top 20 genes physically interact with EGFR ( Figure 3C) 
328
To narrow down candidates for experimental validation, we focused on CDK2 and 329 MSH2, the proteins for which we had IPMS evidence (Figure 3D) (Figure 4A, B) . Next, we incubated purified EGFR protein by itself or with CDK2, 339 along with either its interaction partner Cyclin A2 or Cyclin E1. We found that, in vitro, both 340 Cyclin A and Cyclin E activate CDK2 to phosphorylate EGFR's intracellular regulatory portion 341 (Figure 4C, D) but not to phosphorylate the extracellular portion (Supplemental Fig. 7 
